<$BlogRSDUrl$>

News, Links and Commentary

Monday, February 28, 2005

I Left My Art In San Francisco 

California is the place to be if you're interested in seeing the work of blind photographers. Peter Eckert, a member of the RPList who lost his vision six years ago, is currently showing his work at Varnish Fine Art Gallery until 5 April 2005. From the San Francisco Chronicle:

About five years ago, when Eckert was still coming to terms with his loss of sight, he was cleaning out a drawer at his Sacramento home and found a camera with infrared settings. He thought about how invisible wavelengths might influence a blind person trying to use the camera. A lightbulb came on in his head, and it made him smile.
'Blind Photographer is a Man of Vision,' San Francisco Chronicle, 27 February 2005.

(0) comments |

Tuesday, February 22, 2005

Two Patients Receive European Implants 

Two patients have received electronic implants that may restore sight at Belgium's Catholic University of Louvain-la-Neuve, according to Professor Claude Veraart ('Camera-Mounted Spectacles May Restore Sight - EU', Reuters, 21 February 2005). The implants are the result of a pan-European project involving researchers in France and Germany. They are hoped to be available by 2008-2010.

(0) comments |

Monday, February 21, 2005

RP and Usher Social 2005 Web Page 

Visit the RP & Usher Social 2005 Web page for information about this event to be hosted in Toronto, Canada this July.

(0) comments |

Vision Continues For Photographer With RP 

Photographer and sculptor Alice Wingwall continues to explore the visual arts after losing her sight to retinitis pigmentosa. Her work is currently featured in two exhibits showing at UC Berkeley, 'Blind at the Museum' at UC Berkeley Art Museum and another at the Townsend Center Gallery. Read more about Wingwall and her work in 'Berkeley: Blind photographer's vision extends beyond her eyes' (San Francisco Chronicle, 18 February 2005).

(0) comments |

Sunday, February 20, 2005

Maltese Adaptive Technology Resources 

A recent e-mail enquiry lead me to search for information on Malta and technology for people with disabilities. As a result, I now know about the IT Solutions' Access Technology Group and the Foundation for Information Technology Accessibility.

(0) comments |

Friday, February 18, 2005

Authors With RD Causing A Commotion 

Two very different British authors, both of whom are affected by retinal degeneration, are featured in recent news articles.

Children's author Julie Hearn talks about how she has coped with a recent diagnosis of retinal degeneration in 'On the bright side' (The Times, 5 February 2005).

Thriller writer James H Jackson, author of the Counter-Terrorist Handbook, discusses retinitis pigmentosa as well as tactics to avoid injury in the event of a terrorist attack in ' Keeping an eye on terrorism' (Telegraph, 17 February 2005). While the article doesn't give any specific counter-terrorist strategies for people who can't see grenades or police cordons, the article does include an anecdote about Jackson failing to recognise one of the world's most recognisable women while working on a script with Guy Ritchie.

(0) comments |

Thursday, February 17, 2005

Dates Set For RP Usher Social in Toronto 

The 2005 RP Usher Social is to be held in Toronto, Canada from Thursday 21 July to Monday 25 July.

(0) comments |

Retinal Ganglion Cells Featured In Nature 

Nature this week highlights reseach into retinal ganglion cells that also detect light. The discoveries may lead to possible methods of treating retinal degeneration. Read more in 'nature highlights: Rods and cones... and these' (17 February 2005).

(0) comments |

Sunday, February 13, 2005

South Korean Professor Seeks To Test Stem Cells In RP 

Professor Song Chang-hun of Chosun University in South Korea is seeking government approval to inject stem cells taken from umbilical cord blood into the eyes of five patients with Retinitis Pigmentosa, according to World Peace Herald via United Press International ('Researchers may treat blindness with umbilical stem cells', 12 February 2005).

(0) comments |

Friday, February 11, 2005

Eye - Q Newsletter and Mt Tamborine Trip for Queenslanders 

The first issue of Retina Australia Queensland's Newsletter Eye-Q for 2005 gives information about the research funded by Retina Australia, news for book worms with print disabilities and requests for participants in two QUT research projects - one looking at vision impairment and balance, and another on vision impairment and driving.

The next General Meeting of Retina Australia Queensland will be held on 5 March. Guest speaker will be Robyn Bree, who will be talking on accessible literature and writing.

Retina Australia Queensland has also organised a day trip to Mount Tamborine on Saturday 19 March. The trip will take in Devonshire tea at Cedar Creek Winery and a sausage sizzle at Rosser Park, with an optional guided wine tasting tour or a tour of the Glowworm Caves (additional minimal costs for these tours). The cost of the trip is $25 for members and $30 for non-members, with Devonshire tea and lunch included. For more details, call Retina Australia Queensland on (07) 3229 0482.

(0) comments |

Thursday, February 10, 2005

Further Trials of Optobionics Artificial Silicon Retina 

Trials of Optobionics' Artificial Silicon Retina (ASR) are to be carried out at Chicago's Rush University Medical Center, Johns Hopkins School of Medicine in Maryland, and Emory University School of Medicine / Atlanta VA Medical Center, according to Betterhumans ('Solar Cell Eye Implant Trials Underway,' 9 February 2005).

A reader discussion of the implants can be found at Slashdot: Patients get Solar Implants in Eyes.

(0) comments |

Tuesday, February 08, 2005

Macugen / Pegaptanib Drug Treatment For Wet AMD 

A potential drug treatment for the wet form of age-related macular degeneration, pegaptanib sodium injection (also known as Macugen), was reviewed in the December 30 issue of the New England Journal of Medicine.


In two clinical trials at 117 sites in the United States, Canada, Europe, Australia and South America, doctors found that people treated with the drug early in their illness lost less vision over a one-year period than those who went untreated.
'Rays of hope for macular degeneration' (LA Times, 7 February 2005).


An abstract is available online for the review, titled 'Pegaptanib for Neovascular Age-Related Macular Degeneration' (Evangelos S. Gragoudas and others, New England Journal of Medicine, December 30 2004, Volume 351, pages 2805-2816).

(0) comments |

Thursday, February 03, 2005

Melanopsin Gene Turns On Eye Cells 

Researchers at the Imperial College London and the University of Manchester have found that nerve cells in the eye will respond to light when the melanpsin gene in those cells is activated:

Using mouse cells, the researchers found that melanopsin could be used to make neurones light responsive. They found that as well as being sensitive to blue light, melanopsin uses light at different wavelengths to regenerate itself. In some forms of hereditary blindness photoreceptors are lost entirely, but the retinal ganglion cells, the cells which signal to the brain, remain intact. The researchers believe that by activating the melanopsin, these cells may gain the ability to sense and respond to light.
'Researchers discover way to make cells in the eye sensitive to light' (Imperial College Press Release at EurekAlert January 2005).

The research was published in the January 26 issue of Nature and will now be used in collabortive work on a retinal prosthesis.

(0) comments |

This page is powered by Blogger. Isn't yours?